Identification and characterization of estrogen receptor-related receptor alpha and gamma in human glioma and astrocytoma cells

Molecular and Cellular Endocrinology

Volumn 315, Issue 1-2, 2010, Pages 314-318

  Gandhari, Mukesh K ^a   Frazier, Chester R ^a   Hartenstein, Julia S ^a   Cloix, Jean Francois ^b   Bernier, Michel ^a   Wainer, Irving W ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

3xERE TATA Luc; 4 Hydroxytamoxifen; A 172 cells; AAB TATA Luc; Biochanin A; DY131; ERR ; ERR ; T98G; U87MG; XCT790

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR RELATED RECEPTOR ALPHA; ESTROGEN RECEPTOR RELATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ASTROCYTOMA; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOMA; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; TRANSCRIPTIONAL ACTIVATION;

EID: 71849115893     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.10.001     Document Type: Article

References (37)

1. Ariazi E.A., and Jordan V.C. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr. Top. Med. Chem. 6 (2006) 203-215
2. Baltuch G.H., Dooley N.P., Villemure J.G., and Yong V.W. Protein kinase C and growth regulation of malignant gliomas. Can. J. Neurol. Sci. 22 (1995) 264-271
3. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., and Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126 (2006) 789-799
4. Cheung C.P., Yu S., Wong K.B., Chan L.W., Lai F.M., Wang X., Suetsugi M., Chen S., and Chan F.L. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. J. Clin. Endocrinol. Metab. 90 (2005) 1830-1844
5. Coward P., Lee D., Hull M.V., and Lehmann J.M. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8880-8884
6. Davis D.D., Díaz-Cruz E.S., Landini S., Kim Y.W., and Brueggemeier R.W. Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 108 (2008) 23-31
7. Gelmann E.P. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog?. J. Natl. Cancer Inst. 88 (1996) 224-226
8. Giguère V., Yang N., Segui P., and Evans R.M. Identification of a new class of steroid hormone receptors. Nature 331 (1988) 91-94
9. Giguère V. To ERR in the estrogen pathway. Trends Endocrinol. Metab. 13 (2002) 220-225
10. Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 29 (2008) 677-696
11. Goldenberg G.J., and Froese E.K. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro. Cancer Res. 42 (1982) 5147-5151
12. Greschik H., Wurtz J.M., Sanglier S., Bourguet W., van Dorsselaer A., Moras D., and Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell 9 (2002) 303-313
13. Heard D.J., Norby P.L., Holloway J., and Vissing H. Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol. Endocrinol. 14 (2000) 382-392
14. Hentschke M., Süsens U., and Borgmeyer U. PGC-1 and PERC, coactivators of the estrogen receptor-related receptor γ. Biochem. Biophys. Res. Commun. 299 (2002) 872-879
15. Hong H., Yang L., and Stallcup M.R. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem. 274 (1999) 22618-22626
16. Horard B., and Vanacker J.M. Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J. Mol. Endocrinol. 31 (2003) 349-357
17. Hui A.M., Zhang W., Chen W., Xi D., Purow B., Friedman G.C., and Fine H.A. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Cancer Res. 64 (2004) 9115-9123
18. Huppunen J., and Aarnisalo P. Dimerization modulates the activity of the orphan nuclear receptor ERRγ. Biochem. Biophys. Res. Commun. 314 (2004) 964-970
19. Ingle J.N., Twito D.I., Schaid D.J., Cullinan S.A., Krook J.E., Mailliard J.A., Tschetter L.K., Long H.J., Gerstner J.G., Windschitl H.E., et al. Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis. Cancer 67 (1991) 886-891
20. Jaiyesimi I.A., Buzdar A.U., Decker D.A., and Hortobagyi G.N. Use of tamoxifen for breast cancer: twenty-eight years later. J. Clin. Oncol. 13 (1995) 513-529
21. Joung K.E., Kim Y.W., and Sheen Y.Y. Assessment of the estrogenicity of isoflavonoids, using MCF-7-ERE-Luc cells. Arch. Pharm. Res. 26 (2003) 756-762
22. Kallen J., Schlaeppi J.M., Bitsch F., Filipuzzi I., Schilb A., Riou V., Graham A., Strauss A., Geiser M., and Fournier B. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor α (ERRα): crystal structure of ERRα ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1α. J. Biol. Chem. 279 (2004) 49330-49337
23. Lanvin O., Bianco S., Kersual N., Chalbos D., and Vanacker J.M. Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-α degradation by the estrogen receptor-related receptor-α inverse agonist XCT790. J. Biol. Chem. 282 (2007) 28328-28334
24. Mastronardi L., Farah J.O., Puzzilli F., and Ruggeri A. Tamoxifen modulation of carboplatin cytotoxicity in human U-138 glioma cell line. Clin. Neurol. Neurosurg. 100 (1998) 89-93
25. Parney I.F., and Chang S.M. Current chemotherapy for glioblastoma. Cancer J. 9 (2003) 149-156
26. Prados M.D., Lamborn K., Yung W.K., Jaeckle K., Robins H.I., Mehta M., Fine H.A., Wen P.Y., Cloughesy T., Chang S., Nicholas M.K., Schiff D., Greenberg H., Junck L., Fink K., Hess K., and Kuhn J. North American Brain Tumor Consortium A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro-oncol. 8 (2006) 189-193
27. Razzaque M.A., Masuda N., Maeda Y., Endo Y., Tsukamoto T., and Osumi T. Estrogen receptor-related receptor-γ has an exceptionally broad specificity of DNA sequence recognition. Gene 340 (2004) 275-282
28. Riggins R.B., Lan J.P., Zhu Y., Klimach U., Zwart A., Cavalli L.R., Haddad B.R., Chen L., Gong T., Xuan J., Ethier S.P., and Clarke R. ERRγ mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res. 68 (2008) 8908-8917
29. Robins H.I., Won M., Seiferheld W.F., Schultz C.J., Choucair A.K., Brachman D.G., Demas W.F., and Metha M.P. Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. Neuro-oncol. 8 (2006) 47-52
30. Stupp R., Hegi M.E., van den Bent M.J., Mason W.P., Weller M., Mirimanoff R.O., and Cairncross J.G. Changing paradigms-an update on the multidisciplinary management of malignant glioma. European Organization for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Oncologist 11 (2006) 165-180
31. Suetsugi M., Su L., Karlsberg K., Yuan Y.C., and Chen S. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol. Cancer Res. 1 (2003) 981-991
32. Tremblay G.B., Kunath T., Bergeron D., Lapointe L., Champigny C., Bader J.A., Rossant J., and Giguère V. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR β. Genes Dev. 15 (2001) 833-838
33. Trojan J., Cloix J.F., Ardourel M.Y., Chatel M., and Anthony D.D. Insulin-like growth factor type I biology and targeting in malignant gliomas. Neuroscience 145 (2007) 795-811
34. Willy P.J., Murray I.R., Qian J., Busch B.B., Stevens Jr. W.C., Martin R., Mohan R., Zhou S., Ordentlich P., Wei P., Sapp D.W., Horlick R.A., Heyman R.A., and Schulman I.G. Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8912-8917
35. Wrensch M., Rice T., Miike R., McMillan A., Lamborn K.R., Aldape K., and Prados M.D. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro-oncol. 8 (2006) 12-26
36. Yu D.D., and Forman B.M. Identification of an agonist ligand for estrogen-related receptors ERRβ/γ. Bioorg. Med. Chem. Lett. 15 (2005) 1311-1313
37. Zhang Z., and Teng C.T. Interplay between estrogen-related receptor α (ERRα) and γ (ERRγ) on the regulation of ERRα gene expression. Mol. Cell. Endocrinol. 264 (2007) 128-141